Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Aditxt, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 22 | 18 | −4 |
| Shares | 638.8K | 625.2K | −13.6K (−2.1%) |
| Value | $1.63M | $1.62M | −$11.9K (−0.7%) |
New holders (3)
Institutions that held Aditxt, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 33,484 | $86.0K | 0.00% |
| State Street Corp | 14,228 | $37.0K | 0.00% |
| UBS Group AG | 3,354 | $9.00K | 0.00% |
Sold out (7)
Institutions that held Aditxt, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Virtu Financial LLC | 69,265 | $177.0K |
| XTX Topco Ltd | 10,081 | $26.0K |
| Tower Research Capital LLC (TRC) | 4,114 | $11.0K |
| Royal Bank of Canada | 1,000 | $3.00K |
| Clearstead Advisors, LLC | 300 | $1.00K |
| Hanson & Doremus Investment Management | 455 | $1.00K |
| Carroll Financial Associates, Inc. | 131 | $0 |